Investment Banking
Search documents
Goldman Sachs beats Q3 estimates on investment banking, wealth management performance
Proactiveinvestors NA· 2025-10-14 13:06
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Goldman Sachs and Houlihan Lokey lead in M&A advisory for Q1-Q3 2025
Yahoo Finance· 2025-10-14 12:52
Core Insights - Goldman Sachs has emerged as the leading financial adviser in mergers and acquisitions (M&A) based on deal value, advising on transactions totaling $432.3 billion during Q1-Q3 2025 [1] - Houlihan Lokey has led in deal volume, advising on 240 deals, significantly outpacing its competitors [2] - JP Morgan closely followed Goldman Sachs in deal value, advising on $426.8 billion worth of transactions and 79 billion-dollar deals [3][4] Deal Value - Goldman Sachs advised on 84 billion-dollar deals worth approximately $419 billion, while JP Morgan advised on 79 billion-dollar deals valued at around $411 billion [3] - Other notable advisers include Morgan Stanley, Citi, and Bank of America, with deal values of $389 billion, $273.7 billion, and $256.5 billion, respectively [4] Deal Volume - In terms of deal volume, JP Morgan ranked second with 161 deals, followed closely by Goldman Sachs with 159 deals [4] - Rothschild & Co and Ernst & Young also contributed significantly, advising on 121 and 118 deals, respectively [4] Data Source and Methodology - GlobalData's league tables are based on real-time tracking of various reliable sources, including company and advisory firm websites, with a dedicated team of analysts monitoring these sources for in-depth deal details [5]
X @Bloomberg
Bloomberg· 2025-10-14 12:42
Goldman Sachs Chief Executive Officer David Solomon touted the role of artificial intelligence in driving down costs in the future as the Wall Street giant reported a 14% jump in employee compensation https://t.co/x4GYDHXxDs ...
Goldman Sachs tops estimates as investment banking, bond trading exceed expectations
CNBC Television· 2025-10-14 12:04
Goldman Sachs releasing its quarterly results. Guess who. Leslie's back.She's got that report, too. This is like an absolute marathon at a sprint rolled into one for you today, Les. >> It is.It only happens once every three months. Uh, so we power through. But you're right, Becky.Goldman Sachs out with its report. Significant beats here on the top and bottom lines. Revenue grew 11% in the third quarter to 14.1% billion.That's thanks to sizable gains in the firm's global banking and markets business. Fees Go ...
Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy
Globenewswire· 2025-10-14 12:00
Core Insights - Predictive Oncology Inc. has appointed Shawn Matthews, Thomas McLaughlin, and Sara Turken to its leadership team and Board of Directors to support its new digital asset treasury strategy focused on the Aethir (ATH) token [1][2][3] Leadership Appointments - Shawn Matthews, CEO of DNA Holdings Venture, Inc. and former CEO of Cantor Fitzgerald, joins the Board of Directors [2][3] - Thomas McLaughlin, CIO of DNA Holdings Venture, Inc., is appointed as Chief Investment Officer [2][4] - Sara Turken, JD, a biopharmaceutical veteran, is appointed as General Counsel [2][5] Strategic Focus - The company is leveraging its AI-driven drug discovery capabilities to implement an innovative digital treasury asset strategy, which aims to address its AI requirements and capitalize on the growing global need for AI infrastructure [3][8] - Predictive Oncology operates a digital asset treasury focused on the Aethir (ATH) token, creating the world's first Strategic Compute Reserve [8] Company Background - Predictive Oncology utilizes AI and machine learning to expedite early drug discovery, with its platform, PEDAL, achieving 92% accuracy in predicting tumor responses to drug compounds [6][7] - The company has a biobank of over 150,000 assay-capable heterogeneous human tumor samples, providing extensive AI-based drug discovery solutions [7]
X @The Wall Street Journal
The Wall Street Journal· 2025-10-14 11:42
Goldman Sachs posted a stronger-than-expected profit in the third quarter https://t.co/SAnnjUMMoy ...
Goldman Sachs, Albertsons Report Strong Earnings; China Sanctions Escalate Trade Tensions
Stock Market News· 2025-10-14 11:38
Financial Performance - Goldman Sachs reported adjusted EPS of $12.25 for Q3 2025, exceeding the analyst estimate of $11.00, with net revenue of $15.18 billion, surpassing the estimated $14.10 billion [2][10] - The firm's provision for credit losses was lower than expected at $339 million, compared to an estimate of $369 million [2] - Albertsons reported adjusted EPS of $0.44 for Q2 2025, outperforming the estimated $0.40, with revenue reaching $18.915 billion against an estimate of $18.886 billion [4][10] - Goldman Sachs declared a dividend of $4 per share and achieved a return on equity (ROE) of 14.2% with net income of $4.1 billion [3] Market Developments - The write-off of Credit Suisse's Additional Tier 1 (AT1) capital instruments was revoked, providing clarity and potential relief for impacted bondholders [6][10] - Deutsche Bank and Morgan Stanley raised their target prices for Broadcom Inc., indicating positive sentiment for the semiconductor company [8] Geopolitical Events - China imposed sanctions on South Korean shipbuilder Hanwha Ocean, escalating trade tensions and prohibiting Chinese entities from engaging with Hanwha's U.S.-linked units [5][10] - Chinese Premier Li Qiang emphasized the need for a resilient economy, urging the full utilization of policy resources and counter-cyclical adjustments to stabilize economic growth [7][10]
X @Bloomberg
Bloomberg· 2025-10-14 11:37
Goldman Sachs posted record third-quarter revenues, as a resurgence in dealmaking pushed its investment banking haul past expectations https://t.co/FeJ3hMeN6s ...
Goldman Sachs Profit Surges, Fueled by Dealmaking Boom
WSJ· 2025-10-14 11:37
Investment banking revenue jumped 42% and results beat expectations. ...
Wall Street Warns S&P 500 Dip Buyers of More Turbulence Ahead
Yahoo Finance· 2025-10-14 09:30
Core Viewpoint - Wall Street strategists caution dip buyers that further market volatility may occur despite signals from China and the US indicating a willingness to engage in trade talks [1][2]. Market Performance - The S&P 500 Index increased by 1.6% on Monday, recovering more than half of the losses from Friday, which were driven by renewed tariff tensions [2][6]. - The S&P 500 experienced a 2.7% decline on Friday after President Trump threatened a 100% tariff on goods imported from China, disrupting a period of market stability [6]. Market Sentiment and Predictions - Analysts from firms such as Morgan Stanley, Evercore ISI, and JPMorgan Chase & Co. predict short-term market skittishness due to high valuations and potential economic impacts from the US government shutdown and trade uncertainties [2][4]. - Paisley Nardini from Simplify Asset Management noted that political and fiscal news, along with Federal Reserve policy, is likely to increase market volatility in the latter months of 2025, highlighting the current market's fragility [3]. Correction Risks - Michael Wilson from Morgan Stanley indicated that while pullbacks may present long-term buying opportunities, the S&P 500 is at risk of a correction in the short term, potentially dropping to 5,800 if US-China trade tensions remain unresolved before a November deadline [4]. - Andrew Tyler from JPMorgan expressed concerns about near-term weakness, emphasizing the need for caution due to high equity valuations and uncertain trade negotiations [5].